US 11,723,943 B2
Therapeutic use of chardonnay seed products
Torey James Arvik, Santa Rosa, CA (US); Rebecca Susan Lipson, Santa Rosa, CA (US); and Wallace H. Yokoyama, Albany, CA (US)
Assigned to SONOMACEUTICALS, LLC, Santa Rosa, CA (US); and THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE, Washington, DC (US)
Filed by SONOMACEUTICALS, LLC, Santa Rosa, CA (US); and THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF AGRICULTURE, Washington, DC (US)
Filed on Sep. 14, 2020, as Appl. No. 17/20,533.
Application 17/020,533 is a continuation of application No. 16/145,595, filed on Sep. 28, 2018, granted, now 10,772,924.
Application 16/145,595 is a continuation of application No. 14/398,093, granted, now 10,105,409, issued on Oct. 23, 2018, previously published as PCT/US2013/038696, filed on Apr. 29, 2013.
Claims priority of provisional application 61/798,992, filed on Mar. 15, 2013.
Claims priority of provisional application 61/691,515, filed on Aug. 21, 2012.
Claims priority of provisional application 61/640,622, filed on Apr. 30, 2012.
Prior Publication US 2021/0236579 A1, Aug. 5, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/87 (2006.01); A61P 3/04 (2006.01); A61P 3/10 (2006.01)
CPC A61K 36/87 (2013.01) [A61P 3/04 (2018.01); A61P 3/10 (2018.01)] 18 Claims
 
1. A method of treating metabolic syndrome in a mammal in need thereof comprising administering to the mammal in need thereof an effective amount of Chardonnay pomace flour.